Evidence map›Paper›PMID 27267050›Full record

ArticleBMC complementary and alternative medicine2016

KOTMIN13, a Korean herbal medicine alleviates allergic inflammation in vivo and in vitro.

Eujin Lee, Sun-Gun Kim, Na-Young Park, Hyo-Hyun Park, Kyu-Tae Jeong, Jongkeun Choi, In-Hae Lee, Hwadong Lee, Keuk-Jun Kim, Eunkyung Lee

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nutrients · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eujin LeeResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
Sun-Gun KimResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
Na-Young ParkResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
Hyo-Hyun ParkResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
Kyu-Tae JeongResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
Jongkeun ChoiDepartment of Cosmetic Science, Chungwoon University, Chungnam, 350-701, Republic of Korea.
In-Hae LeeDepartment of Cosmetic Science, Chungwoon University, Chungnam, 350-701, Republic of Korea.
Hwadong LeeResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
Keuk-Jun KimDepartment of Clinical Pathology, Daekyeung University, Gyeongsan, 712-719, Republic of Korea. biomed@tk.ac.kr.
Eunkyung LeeResearch and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea. eklee@ynu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ethanol extract of KOTMIN13, composed of Inula japonica Flowers, Trichosanthes kirilowii Semen, Peucedanum praeruptorum Radix, and Allium macrostemon Bulbs, was investigated for its anti-asthmatic and anti-allergic activities.

methodsThe anti-asthmatic effects of KOTMIN13 were evaluated on ovalbumin (OVA)-induced murine asthma model. Anti-allergic properties of KOTMIN13 in bone-marrow derived mast cells (BMMC) and passive cutaneous anaphylaxis (PCA) in vivo were also examined.

resultsIn asthma model, KOTMIN13 effectively suppressed airway hyperresponsiveness induced by aerosolized methacholine when compared to the levels of OVA-induced mice. KOTMIN13 treatment reduced the total leukocytes, eosinophil percentage, and Th2 cytokines in the bronchoalveolar lavage fluids in OVA-induced mice. The increased levels of eotaxin and Th2 cytokines in the lung as well as serum IgE were decreased by KOTMIN13. The histological analysis shows that the increased inflammatory cell infiltration and mucus secretion were also reduced. In addition, the degranulation and leukotriene C4 production were inhibited in BMMC with IC50 values of 3.9 μg/ml and 1.7 μg/ml, respectively. Furthermore, KOTMIN13 treatment attenuated mast-mediated PCA reaction.

conclusionsThese results demonstrate that KOTMIN13 has anti-asthmatic and anti-allergic effects in vivo and in vitro models.

Indexed as

Herbal MedicineAirway ObstructionAnimalsAnti-Allergic AgentsAnti-Asthmatic AgentsFemaleInflammationMiceMice, Inbred BALB COvalbuminPlant ExtractsAnti-Allergic AgentsAnti-Asthmatic AgentsKOTMIN13OvalbuminPlant ExtractsAirway hyperresponsiveness (AHR)Bone-marrow derived mast cells (BMMC)Bronchoalveolar lavage fluids (BALF)DegranulationLeukotriene C4 (LTC4)Passive cutaneous anaphylaxis (PCA)

Identifiers

PMID27267050
PMCPMC4896024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.